This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
The Board has approved final Dividend of Rs. 4.50/- per share for the year ended March 31 2026
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Smallcap 250 and 4.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Narayana Hrudayalaya's Board approved audited standalone results for FY2026 ending March 31. Revenue from operations grew 10.7% to Rs. 39,751 million from Rs. 35,901 million. EBITDA rose 24.9% to Rs. 10,159 million with margins expanding from 18.7% to 21.1%. Net profit increased 16.7% to Rs. 5,031 million with EPS at Rs. 24.77 versus Rs. 21.23 prior year. The Board recommended a final dividend of Rs. 4.50 per share (face value Rs. 10), subject to shareholder approval at the August 14 AGM. An exceptional charge of Rs. 452.76 million was recorded due to new labour code implementation. Statutory auditors Deloitte issued an unmodified (clean) opinion on the financials.
Positive for shareholders. Strong profit growth, margin expansion, and dividend declaration signal healthy financials. The clean audit opinion reinforces reliability of results.
| Q4 FY26 | Q4 FY25 | Change | |
|---|---|---|---|
| Revenue | ₹2,594 Cr | ₹1,475 Cr | +75.8% |
| Operating profit | ₹264.9 Cr | ₹234.5 Cr | +13.0% |
| Profit after tax | ₹224.0 Cr | ₹197.3 Cr | +13.5% |
| EBITDA margin | 19.7% | 23.7% | −4.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.